<p>The Pfizer/BioNTech coronavirus jab has no link to reported post-vaccination deaths and no new side effects, the EU's medicines regulator said Friday based on the first data from the vaccine's rollout.</p>.<p>The European Medicines Agency said it had looked at the deaths, including a number in the elderly, and "concluded that the data did not show a link to vaccination with Comirnaty (the vaccine) and the cases do not raise a safety concern."</p>.<p>In its first safety update since the EU started its vaccination campaign in December, the Amsterdam-based EMA said that data "is consistent with the known safety profile of the vaccine, and no new side effects were identified."</p>.<p><strong><a href="https://www.deccanherald.com/national/india-nowhere-close-to-achieving-herd-immunity-against-covid-19-944491.html">Read | India nowhere close to achieving herd immunity against Covid-19</a></strong></p>.<p>Reports of occasional severe allergic reactions did not go beyond what had already been found about this "known side effect", it added.</p>.<p>"The benefits of Comirnaty in preventing Covid-19 continue to outweigh any risks, and there are no recommended changes regarding the use of the vaccine," the EMA said.</p>.<p>The EU watchdog has so far approved two vaccines, by Pfizer/BioNTech and Moderna.</p>.<p>It is set to give its verdict on a third, by AstraZeneca, later Friday.</p>.<p>A number of countries, including Norway, Denmark, Finland, Iceland and Sweden, have reported deaths of people who had been given the Pfizer-BioNTech jab but no direct links to the vaccine have been established.</p>.<p>Norway in particular registered 33 deaths among elderly people who had received their first dose.</p>.<p>Oslo said earlier this month it had not established a link but recommended doctors consider the overall health of the most frail before giving them the jab.</p>
<p>The Pfizer/BioNTech coronavirus jab has no link to reported post-vaccination deaths and no new side effects, the EU's medicines regulator said Friday based on the first data from the vaccine's rollout.</p>.<p>The European Medicines Agency said it had looked at the deaths, including a number in the elderly, and "concluded that the data did not show a link to vaccination with Comirnaty (the vaccine) and the cases do not raise a safety concern."</p>.<p>In its first safety update since the EU started its vaccination campaign in December, the Amsterdam-based EMA said that data "is consistent with the known safety profile of the vaccine, and no new side effects were identified."</p>.<p><strong><a href="https://www.deccanherald.com/national/india-nowhere-close-to-achieving-herd-immunity-against-covid-19-944491.html">Read | India nowhere close to achieving herd immunity against Covid-19</a></strong></p>.<p>Reports of occasional severe allergic reactions did not go beyond what had already been found about this "known side effect", it added.</p>.<p>"The benefits of Comirnaty in preventing Covid-19 continue to outweigh any risks, and there are no recommended changes regarding the use of the vaccine," the EMA said.</p>.<p>The EU watchdog has so far approved two vaccines, by Pfizer/BioNTech and Moderna.</p>.<p>It is set to give its verdict on a third, by AstraZeneca, later Friday.</p>.<p>A number of countries, including Norway, Denmark, Finland, Iceland and Sweden, have reported deaths of people who had been given the Pfizer-BioNTech jab but no direct links to the vaccine have been established.</p>.<p>Norway in particular registered 33 deaths among elderly people who had received their first dose.</p>.<p>Oslo said earlier this month it had not established a link but recommended doctors consider the overall health of the most frail before giving them the jab.</p>